Back to Search
Start Over
Clinical and molecular characteristics of AMBITION patients who received olaparib plus cediranib or olaparib plus durvalumab for homologous recombination repair mutated, platinum-resistant ovarian cancer (KGOG 3045) (032)
- Source :
- Gynecologic Oncology. 166:S23
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Oncology
Obstetrics and Gynecology
Subjects
Details
- ISSN :
- 00908258
- Volume :
- 166
- Database :
- OpenAIRE
- Journal :
- Gynecologic Oncology
- Accession number :
- edsair.doi...........a21634ba2a499b02642517e5b4d2066a